Rolien Bosch

Population PK Analyses of Ubrogepant (MK‐1602), a CGRP Receptor Antagonist: Enriching In‐Clinic Plasma PK Sampling With Outpatient Dried Blood Spot Sampling

Chi‐Chung Li, Marissa F. Dockendorf, Ken Kowalski et al. · The Journal of Clinical Pharmacology · 2017 · 43 citations

Pharmacy, Pharmacokinetics, Pharmacology +17

Structural Basis for Agonism and Antagonism for a Set of Chemically Related Progesterone Receptor Modulators

Scott J. Lusher, H.C.A. Raaijmakers, Diep Vu‐Pham et al. · Journal of Biological Chemistry · 2011 · 40 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +17

X-ray Structures of Progesterone Receptor Ligand Binding Domain in Its Agonist State Reveal Differing Mechanisms for Mixed Profiles of 11β-Substituted Steroids

Scott J. Lusher, H.C.A. Raaijmakers, Diep Vu‐Pham et al. · Journal of Biological Chemistry · 2012 · 36 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17

Enantioselective Substrate Binding in a Monooxygenase Protein Model by Molecular Dynamics and Docking

K. Anton Feenstra, Karin Hofstetter, Rolien Bosch et al. · Biophysical Journal · 2006 · 25 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

A novel integrated QSP model of in vivo human glucose regulation to support the development of a glucagon/GLP‐1 dual agonist

Rolien Bosch, Marcella Petrone, Rosalin Arends et al. · CPT Pharmacometrics & Systems Pharmacology · 2021 · 11 citations · Full text

Life Sciences, Endocrinology, Pharmacology +16